Advanced Enzyme (India) Today
ADVENZYMES | 277.10 1.80 0.65% |
PerformanceVery Weak
| Odds Of DistressLow
|
Advanced Enzyme is trading at 277.10 as of the 28th of March 2025; that is 0.65 percent decrease since the beginning of the trading day. The stock's open price was 278.9. Advanced Enzyme has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of December 2024 and ending today, the 28th of March 2025. Click here to learn more.
Moving together with Advanced Stock
Moving against Advanced Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Advanced Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Advanced Enzyme's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Advanced Enzyme or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business Concentration | Specialty Chemicals, Basic Materials, Materials, Chemicals, Specialty Chemicals, Basic Materials (View all Sectors) |
Advanced Enzyme Technologies (ADVENZYMES) is traded on National Stock Exchange of India in India and employs 323 people. Advanced Enzyme is listed under Specialty Chemicals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 31.2 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Advanced Enzyme's market, we take the total number of its shares issued and multiply it by Advanced Enzyme's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Advanced Enzyme Tech operates under Chemicals sector and is part of Materials industry. The entity has 111.88 M outstanding shares.
Advanced Enzyme Technologies has accumulated about 368.43 M in cash with 1.41 B of positive cash flow from operations.
Check Advanced Enzyme Probability Of Bankruptcy
Ownership AllocationAdvanced Enzyme holds a total of 111.88 Million outstanding shares. Advanced Enzyme Technologies retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Advanced Ownership Details
Advanced Enzyme Tech Risk Profiles
Although Advanced Enzyme's alpha and beta are two of the key measurements used to evaluate Advanced Enzyme's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 1.69 | |||
Standard Deviation | 2.16 | |||
Variance | 4.69 | |||
Risk Adjusted Performance | (0.12) |
Advanced Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Advanced Enzyme without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
All Next | Launch Module |
Advanced Enzyme Corporate Management
Elected by the shareholders, the Advanced Enzyme's board of directors comprises two types of representatives: Advanced Enzyme inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Advanced. The board's role is to monitor Advanced Enzyme's management team and ensure that shareholders' interests are well served. Advanced Enzyme's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Advanced Enzyme's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dipak Roda | Senior Development | Profile | |
Beni CA | Chief Officer | Profile | |
Sanjay Basantani | Head Secretary | Profile | |
Martina Doering | MD GmbH | Profile | |
Bhaskar Manolkar | General Administration | Profile |
Additional Tools for Advanced Stock Analysis
When running Advanced Enzyme's price analysis, check to measure Advanced Enzyme's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Enzyme is operating at the current time. Most of Advanced Enzyme's value examination focuses on studying past and present price action to predict the probability of Advanced Enzyme's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Enzyme's price. Additionally, you may evaluate how the addition of Advanced Enzyme to your portfolios can decrease your overall portfolio volatility.